Gold biochips are routinely used by pharmaceutical companies all along their drug discovery process, from drug candidate screening to biomolecular interaction analysis (kinetics, affinity, avidity, etc.), using a Surface Plasmon Resonance (SPR) instrument.

Yet, current biochips show damaging limitations in performance, mostly in specificity when it comes to complex media (cell extract, serum, etc.).

​Kimialys tackes this issue by providing SPR users with off-the-shelf and custom ready-to-use gold biochips, enabling sensitive, robust and reproducible SPR measurements while keeping background noise level at minimum. Our technology works with all types of ligands and SPR instruments, without changing the habits of the user.